Meeting
2015 ASCO Annual Meeting
Genetics of ramucirumab-associated hypertension in the ROSE/TRIO-012 breast cancer trial.
Authors
John Robert Mackey
Cross Cancer Institute, Edmonton, AB, Canada
John Robert Mackey , Oleg N. Lipatov , Miguel Martin , Marc Webster , Roberto Hegg , Sunil Verma , Manuel Ramos Vazquez , Rodrigo Fresco , Francois Thireau , Vincent Houé , Michael F. Press , Ashok Narasimhan , Sambasivarao Damaraju
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 33, 2015 (suppl; abstr 547)
DOI
10.1200/jco.2015.33.15_suppl.547
Abstract #
547
Poster Bd #
35
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Genetic predictor of severe sorafenib-induced diarrhea and hand-foot syndrome (HFS).
First Author: Julia C. F. Quintanilha
Poster
2015 ASCO Annual Meeting
Relationship of germline polymorphisms to docetaxel toxicity in the ROSE/TRIO-012 trial.
First Author: Sambasivarao Damaraju
Poster
2014 ASCO Annual Meeting
ABCB1 polymorphism as a prognostic factor in breast cancer patients with neoadjuvant chemotherapy.
First Author: Hee Jun Kim
Poster
2012 ASCO Annual Meeting
Genetic variants associated with toxicity-related discontinuation of adjuvant aromatase inhibitor (AI) therapy.
First Author: Norah Lynn Henry